In that Dr. Rohrbaugh , the government â€™s bet on a small company like Kite , which might have seemed risky , appears to be paying off so far .Dr. Belldegrun has largely delivered on promises royalties from successful products money , assemble an experienced staff , build the factory , conduct clinical trials and begin to apply for regulatory approval .Once considered the underdog to Novartis and Juno , Kite might be the first reach the market .Academic centers Dr. Belldegrun often drive harder bargains in licensing technology